1、Amino-Functionalized Zirconium-Based Metal–Organic Frameworks as Bifunctional Nanomaterials to Treat Bone Tumors and Promote Osteogenesis.(2023-11-09)

作者：Jongpeng Yuan,Xujie Liu

期刊：ACS Applied Materials & Interfaces

DOI: 10.1021/acsami.3c11787 

影响因子 ：9.5

引用产品：MC3T3-E1, MNNG/HOS and MDA-MB-231 cell

https://pubs.acs.org/doi/full/10.1021/acsami.3c11787

2、Chitosan/NH2-MIL-125 (Ti) scaffold loaded with doxorubicin for postoperative bone tumor clearance and osteogenesis: An in vitro study.（ Pub Date ： 2024-2-23）
作者：Yaoxun Zeng , Jiongpeng Yuan
期刊：International Journal of Biological Macromolecules
DOI: DOI:10.1016/j.ijbiomac.2024.130368
影响因子 ：8.2
引用产品： (MC3T3-E1 cells, ZQ0095)，(RAW264.7 cells, ZQ0098)，(MDA-MB-231 cells, ZQ0118)，(HUVEC cells, ZQY004)
https://www.sciencedirect.com/science/article/pii/S0141813024011711?via%3Dihub

3、论文标题： Prognostic value of gamma-interferon-inducible lysosomal thiol reductase expression in female patients diagnosed with breast cancer
DOI： 10.1002/ijc.33843
发表时间： 2021-10-25
期刊： INTERNATIONAL JOURNAL OF CANCER
影响因子： 7.396
货号： ZQ0118
产品名称： MDA-MB-231 cells
原文链接： https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.33843

4、论文标题： LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer
DOI： 10.3389/fonc.2021.678474
发表时间： 2021-05-07
期刊： Frontiers in Oncology
影响因子： 6.244
货号： ZQ0118
产品名称： MDA-MB-231 cells
原文链接： https://www.frontiersin.org/articles/10.3389/fonc.2021.678474/full

5、论文标题： The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis
DOI： 10.1186/s12935-021-02113-5
发表时间： 2021-08-21
期刊： Cancer Cell International
影响因子： 5.722
货号： ZQ0118
产品名称： MDA-MB-231 cell
原文链接： https://link.springer.com/article/10.1186/s12935-021-02113-5

6、论文标题： Long non-coding RNA ROR recruits histone transmethylase MLL1 to up-regulate TIMP3 expression and promote breast cancer progression
DOI： 10.1186/s12967-020-02682-5
发表时间： 2021-03-02
期刊： Journal of Translational Medicine
影响因子： 5.531
货号： ZQ0118
产品名称： MDA-MB-231 cell
原文链接： https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02682-5

7、论文标题： MMP-2 sensitive poly(malic acid) micelles stabilized by π–π stacking enable high drug loading capacity
DOI： 10.1039/D0TB01682A
发表时间： 2020-08-11
期刊： Journal of Materials Chemistry B
影响因子： 5.344
货号： ZQ0118
产品名称： MDA-MB-231 cells

原文链接： https://pubs.rsc.org/en/content/articlelanding/2020/tb/d0tb01682a

8、论文标题： T-17, a novel cyclin-dependent kinases/histone deacetylases dual inhibitor, induces cancer cells death through cell cycle arrest and apoptosis
DOI： 10.1002/ddr.21977
发表时间： 2022-07-17
期刊： DRUG DEVELOPMENT RESEARCH
影响因子： 5.004
货号： ZQ0118
产品名称： MDA-MB-231 cell
原文链接： https://onlinelibrary.wiley.com/doi/abs/10.1002/ddr.21977

9、论文标题： Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer
DOI： 10.1155/2021/9219961
发表时间： 2021-11-27
期刊： Journal of Oncology
影响因子： 4.375
货号： ZQ0118
产品名称： MDA-MB-231 cell
原文链接： https://www.hindawi.com/journals/jo/2021/9219961/

10、论文标题： METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression
DOI： 10.3892/or.2020.7515
发表时间： 2020-02-24
期刊： ONCOLOGY REPORTS
影响因子： 3.417
货号： ZQ0118
产品名称： MDA-MB-231 cells
原文链接： https://www.spandidos-publications.com/10.3892/or.2020.7515

11、论文标题： SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma
DOI： 10.1007/s00432-018-2584-x
发表时间： 2018-01-25
期刊： JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
影响因子： 3.282
货号： ZQ0118
产品名称： MDA-MB-231 cells
原文链接： https://link.springer.com/article/10.1007/s00432-018-2584-x

12、论文标题： P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling
DOI： 10.1007/s11010-018-3281-4
发表时间： 2018-01-31
期刊： MOLECULAR AND CELLULAR BIOCHEMISTRY
影响因子： 2.561
货号： ZQ0118
产品名称： MDA-MB-231 cells
原文链接： https://link.springer.com/article/10.1007/s11010-018-3281-4

13、论文标题： Long Non-Coding RNA A2M-AS1 Promotes Breast Cancer Progression by Sponging microRNA-146b to Upregulate MUC19
DOI： 10.2147/IJGM.S278564
发表时间： 2020-11-27
期刊： International Journal of General Medicine
影响因子： 1.927
货号： ZQ0118
产品名称： MDA-MB-231 cells

原文链接： https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7708314/

14、PubMed=27331101; DOI=10.1016/j.dib.2016.05.040

Aumsuwan P., Khan S.I., Khan I.A., Walker L.A., Dasmahapatra A.K.
Gene expression profiling and pathway analysis data in MCF-7 and MDA-MB-231 human breast cancer cell lines treated with dioscin.
Data Brief 8:272-279(2016)

15、PubMed=27377824; DOI=10.1038/sdata.2016.52
Mestdagh P., Lefever S., Volders P.-J., Derveaux S., Hellemans J., Vandesompele J.
Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR.
Sci. Data 3:160052-160052(2016)

16、PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

17、PubMed=27807467; DOI=10.1186/s13100-016-0078-4
Zampella J.G., Rodic N., Yang W.R., Huang C.R.L., Welch J., Gnanakkan V.P., Cornish T.C., Boeke J.D., Burns K.H.
A map of mobile DNA insertions in the NCI-60 human cancer cell panel.
Mob. DNA 7:20.1-20.11(2016)

18、PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

19、PubMed=28287265; DOI=10.1021/acs.jproteome.6b00470
Yen T.-Y., Bowen S., Yen R., Piryatinska A., Macher B.A., Timpe L.C.
Glycoproteins in claudin-low breast cancer cell lines have a unique expression profile.
J. Proteome Res. 16:1391-1400(2017)

20、PubMed=28889351; DOI=10.1007/s10549-017-4496-x
Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L., Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E., Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J., Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E., Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F., Lakhani S.R.
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Breast Cancer Res. Treat. 167:289-301(2018)

21、PubMed=29273624; DOI=10.1101/gr.226019.117
Franco H.L., Nagari A., Malladi V.S., Li W.-Q., Xi Y.-X., Richardson D., Allton K.L., Tanaka K., Li J., Murakami S., Keyomarsi K., Bedford M.T., Shi X.-B., Li W., Barton M.C., Dent S.Y.R., Kraus W.L.
Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
Genome Res. 28:159-170(2018)

22、PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

23、PubMed=30971826; DOI=10.1038/s41586-019-1103-9
Behan F.M., Iorio F., Picco G., Goncalves E., Beaver C.M., Migliardi G., Santos R., Rao Y., Sassi F., Pinnelli M., Ansari R., Harper S., Jackson D.A., McRae R., Pooley R., Wilkinson P., van der Meer D.J., Dow D., Buser-Doepner C.A., Bertotti A., Trusolino L., Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature 568:511-516(2019)

24、PubMed=31068700; DOI=10.1038/s41586-019-1186-3
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)

25、PubMed=31092827; DOI=10.1038/s41467-019-10148-6
Liu K., Newbury P.A., Glicksberg B.S., Zeng W.Z.-D., Paithankar S., Andrechek E.R., Chen B.
Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data.
Nat. Commun. 10:2138.1-2138.12(2019)

26、PubMed=31978347; DOI=10.1016/j.cell.2019.12.023
Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E.T., Schweppe D.K., Jedrychowski M.P., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P.
Quantitative proteomics of the Cancer Cell Line Encyclopedia.
Cell 180:387-402.e16(2020)

27、PubMed=32782317; DOI=10.1038/s41598-020-70393-4
Risha Y., Minic Z., Ghobadloo S.M., Berezovski M.V.
The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers.
Sci. Rep. 10:13572-13572(2020)

28、PubMed=34238275; DOI=10.1186/s12885-021-08511-2
Samson J., Derlipanska M., Zaheed O., Dean K.
Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010.
BMC Cancer 21:790.1-790.20(2021)

29、PubMed=34320349; DOI=10.1016/j.celrep.2021.109441
Jochems F., Thijssen B., De Conti G., Jansen R., Pogacar Z., Groot K., Wang L.-Q., Schepers A., Wang C., Jin H.-J., Beijersbergen R.L., Leite de Oliveira R., Wessels L.F.A., Bernards R.
The cancer SENESCopedia: a delineation of cancer cell senescence.
Cell Rep. 36:109441.1-109441.22(2021)

30、PubMed=35042871; DOI=10.1038/s41523-021-00379-6
Rypens C., Bertucci F., Finetti P., Robertson F.M., Fernandez S.V., Ueno N.T., Woodward W.A., Van Golen K., Vermeulen P., Dirix L., Viens P., Birnbaum D., Devi G.R., Cristofanilli M., Van Laere S.
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC.
NPJ Breast Cancer 8:12.1-12.12(2022)

31、PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)